The headline numbers for KKR & Co. (KKR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The investment firm is set to acquire a majority stake in HealthCare Royalty Partners, according to people familiar with the matter.
KKR is in talks to buy ST Telemedia Global Data Centres in a deal that could value the Asian digital infrastructure provider at more than $5 billion, Bloomberg News reported on Saturday, citing people familiar with the matter.
EU antitrust regulators will investigate whether U.S. investment firm KKR provided incorrect or misleading information in its 22-billion-euro ($26 billion) acquisition of Telecom Italia's (TIM) fixed-line network deal, the European Commission said on Thursday.
KKR stock trades at about 20 times the consensus estimate for around $6.65 a share in earnings next year.
Fee-related earnings and AUM continue to grow steadily. The insurance business caused short-term volatility but has long-term potential. Market risks and low realizations remain, but the business model is resilient.
KKR & Co. Inc. boasts strong fundamentals, outperforming SPY and peers, with a robust asset base and investment-grade credit ratings. The company has a 14-year streak of uninterrupted dividends, with recent consecutive increases, highlighting its commitment to shareholder returns. Among KKR's baby bonds, KKRS offers a standout 7.01% yield to worst.
In the late 1980s, KKR made its name as the most feared corporate raider in America, immortalised in the book Barbarians at the Gate. That legendary deal, a hostile, record-breaking takeover of RJR Nabisco, became symbolic of an era when private equity investors ruthlessly stormed company boardrooms, reshaping entire industries.
Private equity group KKR will acquire ProTen, one of Australia's largest broiler chicken growers, from pension fund Aware Super, the parties said in a joint statement on Wednesday without disclosing financial details.
We tracked three new preferred stock and ETD offerings this month, with yields from 6.875% to 10%, highlighting KKR, MicroStrategy, and PennyMac. KKR's new subordinated notes stand out with a perfect compliance score, BBB+ rating, and a 6.875% yield, making it a top-quality pick. MicroStrategy's new non-cumulative preferred offers a high yield but lacks mandatory dividends, while insider buying signals confidence.
Market volatility, triggered by trade tensions and tariffs, has exposed risks even for leading private credit players like FSK. FSK's attractive 13%+ dividend yield could face imminent risks, as adjusted NII per share may not fully cover distributions through 2025 and 2026. Despite a resilient and diversified portfolio, ongoing rate headwinds and execution risks justify a cautious stance on FSK.
U.S. private equity firm KKR and Assura have agreed on the terms of a "best and final" offer for the British healthcare real estate investor's sale, valuing it at nearly 1.7 billion pounds ($2.29 billion), the companies said on Wednesday.